Flu

Thrifty White’s experiences provide practical lessons from designing, training, and standardizing a full-system model.

Pharmacists boost late-season flu, COVID-19, and RSV vaccination with coadministration guidance, fatigue-fighting messaging, and community access strategies.

The FDA accepts Moderna’s mRNA flu vaccine filing, targeting adults 50 years and older, with an accelerated path for older adults and a 2026 decision deadline.

The FDA declines to review Moderna’s mRNA flu vaccine filing over comparator choice, despite positive phase 3 results.

Various OTC analgesic and anesthetic products can be effective in providing prompt, temporary relief from discomfort.

Pharmacists enhance community health by offering test-and-treat services for COVID-19, influenza, strep, and RSV, improving access to care.

According to the news release, the manufacturers have 30 days to respond.

Discover how AI-engineered nasal antiviral platforms revolutionize flu prevention, enhancing mucosal immunity and offering new treatment possibilities.

Pharmacists can educate patients about FluMist for at-home administration and opioid labeling changes.

Researchers explore how immune history and innovative vaccine technologies enhance protection against flu, highlighting pharmacists' vital role in patient education.

New research reveals significant nonrespiratory complications in hospitalized children with influenza, highlighting the need for improved clinical awareness and antiviral treatment.

Counsel patients about effective remedies for pediatric colds, sore throats, and safe OTC options for adults with hypertension to alleviate symptoms.

Influenza significantly impacts agricultural workers in the Americas, highlighting urgent vaccination needs for public health and food security.

Flu vaccination during pregnancy safeguards maternal and infant health, reducing severe illness risks and providing essential immunity to newborns.

Researchers uncover how apolipoprotein D (ApoD) increases influenza severity in older adults, highlighting the need for enhanced vaccines and new therapeutic strategies.

Pediatric flu cases surge, revealing alarming rates of encephalopathy.

The BMJ study highlights that young children vaccinated against influenza in October experience the greatest protection, with lower infection rates than those vaccinated earlier.

Research reveals how aging impacts flu severity in older adults, highlighting the need for enhanced vaccines and new therapeutic strategies.

New findings suggest high-dose influenza vaccines offer better protection against the flu and reduce cardiac complications in older adults.

FluMist Home, the first at-home nasal spray flu vaccine, is now available for direct delivery to patients in 34 US states.

Researchers unveil a promising drug combination, arainosine and theobromine, that effectively targets influenza A M2 channels, outperforming existing treatments.

New research confirms oseltamivir (Tamiflu; Roche) is safe for children, reducing flu-related neuropsychiatric risks and encouraging timely antiviral treatment.

Collaborating with local organizations strengthens trust and can influence vaccination uptake.

Understanding the regulatory landscape can maximize pharmacists' roles while ensuring legal compliance.